Forum Topics KYP KYP KYP valuation

Pinned valuation:

Added 4 weeks ago
Justification

Three weeks ago when Kinatico released its Q2 results I noted in a previous straw; this was an interesting business which I would like to own, but at what price?

I’ve been nibbling a bit since then while trying to get a better grasp on a valuation for the business.

Kinatico’s revenue has been quickly shifting toward SAAS. Until recently the market was grasping at SAAS businesses with great enthusiasm. However, that all changed over the last month as Anthropic released its new Claude legal product. The market is now worried about AI applications extending to other industries and competing directly with existing SAAS businesses. The big question now is, “will AI eat the lunch of all/most/some SAAS businesses, or will it actually benefit some SAAS businesses?” I don’t know the answer to that.

Kinatico’s switch to mostly SAAS revenue (58% of revenue in Q2 FY2026) has come at a bad time. With a market cap of just $90 million and with the future of SAAS questionable, Kinatico’s share price has been taking a pummelling lately. Yesterday Kinatico shares traded as low as 17 cps, closing at 17.5 cps (down 14.6% for the day). The share price has halved from its all time high of 34 cps in November 2025.

Kinetico is on the verge of potentially growing its earnings in excess of 50% per year through rapidly increasing revenues and some margin improvement. It is only 3 weeks out from a very positive announcement that confirms the business is on track with over 40% growth in SAAS revenue, yet the share price was down 17.5% at one point yesterday! Perhaps it was just overpriced late last year and it is now starting to look like reasonable value?

Kinatico Ltd provides screening, verification, and SaaS-based workforce management and compliance technology systems in Australia and New Zealand. The company offers Kinatico Compliance, a SaaS-based compliance solution that offers simplified people management workflows to streamline the entire employee lifecycle; and Kinatico CVCheck, which provides pre-employment screening services. It also provides a suite of software solutions that enables scalable compliance monitoring, including pre-employment to real-time requirements related to geo-location, roles, and activities applicable across a range of industries (Simply Wall Street).

Could this workflow be easily disrupted by AI? I have no idea at this point in time, but it is certainly a risk!

Three weeks ago (14 January 2026) Kinatico CEO Michael Ivanchenko said: "Annualised SaaS revenue has grown 42% to $19.7m, with SaaS now representing 58% of quarterly revenue. This is clear evidence of the success of our strategy. At the same time, we have launched our new solution, Kinatico Compliance continues to resonate with SMEs and also large enterprise. The combination of the ongoing operational performance and the addition of our new solution gives confidence that we are well positioned for continued momentum. Disciplined execution, while remaining cash accretive reflects the operational leverage emerging in the business. To the Kinatico team—thank you for your continued commitment to our customers and delivery of our common goals. These results are yours.”

For such a small business I am surprised by the analyst coverage on Simply Wall Street.

c87b869c7f128899f7c776e94784e5eb9db830.jpeg

Most of the analysts could be sipping from the same Kool-aid, because there is reasonably good agreement on future earnings growth for the business. The Q2 FY26 result supports the thesis the business is on track to achieving very strong revenue and earnings growth. Consensus is that EPS will grow over 50% annually over the next few years. I think that’s feasible given H1 2026 SAAS revenue was up 49% on the same time last year.

Analysts are forecasting earnings to be 6 times higher in FY2028 (ie. 0.269 cps in FY25 to 1.7 cps in FY28).

Currently KYP is currently trading on 80x FY25 earnings (0.27 cps) which sounds expensive. However, PE is forecast to be 41x in FY26 (0.5 cps per share), 17x in FY27 (1 cps per share), and 10x in FY28 (1.7 cps per share). That’s providing everything goes smoothly, the business remains competitive in the space, and it is not disrupted by AI. There’s a lot that can go wrong.

Valuation

Over the last 2 years Kinetico shares have traded on a PE between 77x and 32x earnings, with a midpoint of 54x. Assuming revenue continues to grow at 40% annually and margins improve slightly, it’s feasible earnings could 1 cps in FY27. At a PE of 25x that would make Kinetico worth 25 cps in FY27. Discounting back at 10% per year, the valuation comes back at about 20 cps.

Analyst consensus 1yr price target is 45 cps.

I ran Kinetico fundamentals through McNiven's Valuation formula, assuming equity of 7 cps, ROE of 15%, 100% of earnings reinvested. At the current price of 17.5 cps the annual return would be 9%. This isn’t a high ROI, however I expect ROE will improve quickly and by FY28 could be over 20%. I think the business is close to an earnings growth and ROE inflexion point (see graph below).

ef73433523e25b6d546d9b0df624e3206604d4.jpeg

Analyst forecasts (consensus of five analysts on Simply Wall Street).

Kinetico has no debt and over $10 million in cash, so there is little risk of a capital raising.

I have gradually added Kinetico shares IRL over the last week and intend to add more on further share price weakness. I see excellent value in Kinetico at the moment given the current earnings growth forecasts.

Held IRL (0.4%)

mikebrisy
Added 4 weeks ago

@Rick interesting business, I agree. Also a shout out to @jcmleng for your deep dive into the companya while ago. That's a great resource.

As I've looked at is, one question I have (among many) is gross margin evolution.

From 2018 to 2024 %GM increased steadily from 51% up to 67%, in the way we are used to seeing as SaaS companies scale.

However, - with what I can only take as being due to the launch of Kinatico Compliance - we saw in FY25 the gross margin step back down to 65%. Now I am yet to trawl through the available transcripts, and I imagine the explanation is given there. And I wonder if it because the Compliance product has to interface with external systems to perform checks and that these checking transactions carry a fee?

So my question is for those who have looked at this more deeply than I have:

1) Why did %GM step down in FY25?

and, more importantly,

2) How are you thinking about the evolution of %GM in the future - next 10 years?

It the step down is due to the contribution of external fees from Complaince SaaS, and if the SaaS product is growing at double the rate of the business, what is the %GM trajectory?


Unsurpisingly, $KYP has been beaten down with other SaaS stocks, which it interesting because it wasn'y very high rated to begin with.

It is in a space with lots of competitors, and I think it is interesting in eyeing Asia for potential overseas expansion. Of course, it has a large market in ANZ for which it has barely scratched the surface. For example, just looking at a few segments where people compliance is important, the Aussie work force in aged care, child care, and disability services is around 1 million people. This space is dominated by SMBs, the large majority of whom are not sophisticated software buyers.

I'm not a buyer yet, because I prefer to invest in global leaders, but the track record of $KYP in building a profitable, cash generative business, while still a SaaS microcap is pretty impressive and a testament to the quality of the management team. Depending on how the numbers fall, its valuation could be very undemanding.

DIsc: Not held, but looking --- after all, there's no such thing as too much SaaS in a portfolio!!

21

Tom73
Added 4 weeks ago

@mikebrisy , I watched the SM meeting on the weekend and like you started looking at Kinatico, the price drop and lower PE sparking my interest. Having read all the great work done on SM (special call out to @jcmleng ), here are my first thoughts on a first pass on Kinatico with only a very limited analysis of the numbers.

Factors to consider/issues/points (no particular order or weighting)

·        The CEO does not have much skin in the game: CEO only holds 105k shares (ie <$20k) and is on a $422k base salary. LTI give him 4m zero priced options if he sticks around to FY27, plus he has 5m loan funded shares (2m for sticking around to FY27 and 3m for sticking around to FY27 and a 16c sp) – unsure what price the loan is at… Sure he win’s big if shareholders do, but he still does nicely if shareholders loose.

·        Operating Leverage: tipped into profit recently so PE will drop quickly provided operating leverage remains strong for the next few years (Opportunity for market miss pricing or overlooking). Would expect better GM% due to SAAS, so the GM% drop in FY25 from 66.9% to 64.8% is odd, but possibly an aberration of switching – keep an eye on.

·        Sales Growth: Company is focused on SAAS revenue growth, failing to talk to what is very slow sales growth over the last few years for a marginally profitable SAAS business (lucky to meet a rule of 15 let along 40). Sales grew 5%, 4%, 12% YoY to FY25 and 13% for H1 FY26 on a PcP basis from the Q2 Flash. 

·        SAAS Growth: The company has changed it’s revenue model last year and is rotating sales into the new SAAS rather than transaction pricing, which is good but headlining SAAS growth in announcements when most of it’s just transition to hide poor overall growth is an issue. Maybe once the switch is complete growth will kick up – TBD.

·        Limited TAM: as per @jcmleng ’s Pt 2 straw the market size is US$75-125m (A$110-180m) of which they currently have $32.6m in sales or 18-30% of the market, which is a high portion and as a result limits growth. @Strawman ’s notes mentions a medium term target by the company of $75-90m in sales in 3-5 years, which allowing for some market growth will put that at 40-60%. Any sort of effective competition is going to kill growth.

·        Overseas risk: the very nature of the product (Regulation Tech) means that you can’t cookie cut your product into overseas markets, so it’s is almost a different product. I am concerned that the limited TAM in Australia will force o/s expansion with $10m in the bank offering an acquisition approach which adds different risks again. The complete lack of growth in sales in NZ is maybe an indication of cross jurisdictional incompatibility (need to verify).

·        CEO mentioned reducing headcount from 134 to 70 while doubling revenue, which implies savings and efficiencies.  I assume he is referring to FY21 ($17.5m sales) to FY25 ($32.1m sales) but why has employee cost gone up 57% over that period when head count has basically halved? Note most of this cost uplift occurred in FY22, employee costs are close to flat from FY22-25, but sales growth was a total of 22% over that 3 years.

·        FCF positive: With ComplianceX now in market a pull back on capex would significantly enhance already strong FCF. The strong cash generation along with a strong balance sheet puts the business into a low risk zone – but the benefit to shareholders will be highly dependent on managements effective use of this cash. They have been around for a very long time, so are likely to continue to be, but shareholder returns have only been achieved by timing buy and sell points (IPO in 2015 at $0.20 a share)!

My feel is that if sales can grow at low double digits until FY30 and any use of cash is value adding to shareholders, then the current price of $0.18 is very good. For it to be a 5-10 bagger (beyond irrational market pricing), then they are going to have to find other avenues of growth other than ComplianceX in Australia, there isn’t the head room.

I will play around with figures and models to see what else I can understand or see, but this business needs to change and can’t remain the way it currently stands to be a big winner. I currently don’t have the confidence in management to expect them to generate great returns for shareholders – but they may well do it and I may with a closer look find some faith.

I am not even thinking about the AI/SAAS issue… not that I think it is one near term.

Undecided, maybe too hard.

20

jcmleng
Added 4 weeks ago

I have been watching the price drop and just had a quick re-look at my notes from Dec 2025. I had 3 concerns then, probably heightened now, after SAAS-wreck:

1. The PE at $0.30 (when I contemplated a small nibble) was ~107x. At $0.18 it is 65x - thats XRO-like, which post SAAS-wreck, is a much bigger challenge vs say 6 weeks ago. My valuation was based on PE scenarios of 75 ($0.19), 100 ($0.53), 135 ($0.31) - quite a bit of an issue in this post SAAS-wreck era.

2. TAM Expansion outside of ANZ - as @Tom73 outlined above

3. Moat - focus on useability rather than compliance requirement - my deal breaker then. I am more nervous now as this is a space where the current, albeit highly superficial thinking, is that AI might mess things up. I can't quite see how, as all my points about replacing enterprise software still hold true, but I don't like that it is in the crosshairs of the narrative, at least in the short term. This is offset by Michael saying they had a "AI first" mindset in the company, Not sure how it has been baked into the solution vs, say XRO's approach in baking its JAX AI agent into its workflows (my current "reference point" as to what good AI embedding possibly looks like).

The combo of the 3 still makes it problematic for me at these levels.

13

twee
Added 4 weeks ago

@mikebrisy I own - my portfolio agrees on never having too much SaaS!

On the GM question, the CEO had that question in the FY25 results (https://youtu.be/d2IoY4Zprsc?t=2120). Essentially. he sidestepped why and went on to say it will grow. 

As you suggest my understanding is that they are paying the external fees to do the checks so they need to grow seats (perhaps untimely given AI agent potential) to improve margins. 

I think odds are margins will grow in the short term towards 85%, in the long term (10 yrs) I'm more pessimistic and I don't have a strong view on this.

For me the growth of the SaaS platform covers its sins.

11

Tom73
Added 4 weeks ago

@jcmleng , I see points 1 & 2 as very much two sides of the same coin. Point 1, the PE at 65 or even 107 is not the same issue for KYP as XRO, because KYP is coming of a very low base where a 15-20% top line growth could increase earnings 100-200% and bam your PE is down to something reasonable. However the point 2 may limit sales growth, or require more cost to get growth so lower operating leverage.

Regarding 3 – moat, I don’t understand the market or product well enough to say they have one or it is defendable. In these cases I rely on sales growth or margin growth to help me understand if it has a product that is in demand and hard to replicate. AI may not be an issue because they have such a small market (low TAM, niche defence) and deal with companies that are not going to spin up their own AI solution in place of a SAAS option.

15

RogueTrader
Added 4 weeks ago

DMX Asset Management has been a longtime supporter of KYP - from their latest report:

"While KYP’s second quarter SaaS revenue of $4.9m was up 42%, and its first half SaaS revenue of $9.7m increased 49%, these pleasing numbers masked a slowdown in quarter-on-quarter incremental SaaS growth to $100k ($400k annualised). KYP’s first half SaaS exit rate growth decelerated from 59% at the end of the first quarter to 41%. This slowdown was attributed to KYP transitioning from selling its legacy compliance offering to its new generation organisational compliance management platform which was launched during the quarter. We would expect growth to re-accelerate in the second half as its marketing ramps up and the new product gets traction. However, with KYP’s growth momentum interrupted, and the market increasingly nervous around software stocks, its shares were sold off by 33% during the month. 

We remain confident in the potential here for KYP, with its historical track record of strong SaaS growth suggesting there should be plenty of demand for its new product. With its strong balance sheet, emerging operating leverage and market opportunity (both domestically and internationally), we continue to believe KYP represents one of the better value/growth propositions of ASX listed SaaS exposures."

Also some good analysis of EDU, PPL, ABV and AER: Jan 2025 Monthly Report - DMXAM (It says 2025 but that's a typo)

Their other funds monthly report also always worth reading: Jan 2026 Monthly Report - DMXAM

12